Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • IBM, Broad Institute Launch Initiative Using Genomics & AI To Predict Risk Of Cardiovascular Disease

    Bio-IT World News Brief | IBM Watson Health and the Broad Institute are expanding their partnership to help clinicians better predict the possibility of serious cardiovascular diseases.

    Feb 14, 2019
  • Data Is The Key Ingredient To Digital Transformation

    Bio-IT World Contributed Commentary | The pharmaceutical industry needs a data transformation before it can realize its digital transformation—and most companies recognize the urgency.

    Feb 13, 2019
  • Trump To Sign Executive Order Promoting Artificial Intelligence

    The New York Times | President Trump is expected to sign an executive order meant to spur the development and regulation of AI. But the order does not set aside additional funds for AI development, and officials provided few details on how it will track the progress of its new policies.

    Feb 11, 2019
  • Clinical Genomics Insights In Hematological Malignancies Require Streamlined Bioinformatics Solutions

    Bio-IT World Contributed Commentary | Next-generation sequencing has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors have set the foundation for genomics-guided precision medicine; but, for hematological malignancies, the path to precision medicine is a lot more complex.

    Feb 8, 2019
  • Oxford Nanopore Launches cDNA Kits

    Bio-IT World News Brief  Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology.   The new kits provide high throughput while generating complete sequences of full-length cDNA strands, with a low input option of just 1 ng PolyA+ RNA.

    Feb 5, 2019
  • «
  • 281
  • 282
  • 283
  • 284
  • 285
  • 286
  • 287
  • 288 (current)
  • 289
  • 290
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy